Učitavanje...
Improved survival of patients with melanoma brain metastases in the era of targeted BRAF and immune checkpoint therapies
BACKGROUND: The development of brain metastases is common for systemic treatment failure in melanoma patients and has been associated with a poor prognosis. Recent advances with BRAF and immune checkpoint therapies have led to improved patient survival. We evaluated the risk of de novo brain metasta...
Spremljeno u:
| Izdano u: | Cancer |
|---|---|
| Glavni autori: | , , , , , , , , , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
2017
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7771556/ https://ncbi.nlm.nih.gov/pubmed/29023643 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cncr.30946 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|